Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer

Status unconfirmed

Conditions studied: Prostate Cancer

In brief

The purpose of this research study is to assess outcomes of treatment for early prostate cancer. Current treatments for early (non-metastatic) cancer may cause long-term impairments in the patients quality of life. In this study we will compare the outcomes of patients treated with two alternative brachytherapy (seed implants) techniques using a series of questionnaires.

Key facts

Study ID

NCT00681694

Run by

Massachusetts General Hospital

People needed

414

Starts

2002-03-01

Expected to finish

2011-03-01

Last updated by the study team

2010-04-28

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Pathological diagnosis of an adenocarcinoma of the prostate
• 18 years of age or older
• Prior choice of either standard brachytherapy or MRIGPB as primary treatment

You may not qualify if…

• Prior primary therapy (surgery or external beam radiation) for prostate cancer
• Current hormone ablation therapy

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)
• Dana-Farber Cancer Institute/Brigham and Women's Hospital — Boston, Massachusetts, United States (enrolling)
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.